Alexander Gaffney of raps.org details that the US Food and Drug Administration (FDA) is ready to launch a new work group, the Program Alignment Group (PAG). The goal in creating PAG is to streamline efforts from various organizations and centers of FDA to avoid duplication, reduce complexity, and increase globalization efforts. There are six core initial areas that the PAG will begin to focus on that deal with specialization, training, new work planning, compliance policies, lab optimization, and center/ ORA practices. FDA commissioner, Margaret Hamburg says it will take time and resources for the PAG to become a fully functioning group, but it has her full support. To read the full article, click here.
Obstacles Facing Biosimilars
Still in its infancy in the U.S., the industry faces some growing pains.
Life Science Accelerated
Our experts are dedicated to expediting life science product development regulatory pathways.